Mechanism of suppression of cardiac L-type Ca 2+ currents by the phospholipase A 2 inhibitor mepacrine

By Xiao Y.-F.   Zeind A.J.   Kaushik V.   Perreault-Micale C.L.   Morgan J.P.  

European Journal of Pharmacology, Vol. 399, Iss. 2, 2000-07 ,pp. : 107-116

Elsevier

Access to resources Recommend Favorite

17 -Estradiol inhibits the voltage-dependent L-type Ca 2+ currents in aortic smooth muscle cells

By Nakajima T.   Kitazawa T.   Hamada E.   Hazama H.   Omata M.   Kurachi Y.  

European Journal of Pharmacology, Vol. 294, Iss. 2, 1995-12 ,pp. : 625-635

Elsevier

Access to resources Recommend Favorite

Effects of semotiadil, a novel Ca 2+ channel antagonist, on the electrical activity of Langendorff-perfused guinea pig hearts in comparison with diltiazem, amlodipine and nifedipine

By Stark G.   Kasper K.   Stark U.   Miyawaki N.   Decrinis M.   Tritthart H.A.  

European Journal of Pharmacology, Vol. 286, Iss. 1, 1995-11 ,pp. : 71-78

Elsevier

Access to resources Recommend Favorite

The binding interactions of Ro 40-5967 at the L-type Ca 2+ channel in cardiac tissue

By Rutledge A.   Triggle D.J.  

European Journal of Pharmacology, Vol. 280, Iss. 2, 1995-07 ,pp. : 155-158

Elsevier

Access to resources Recommend Favorite

Inhibition of recombinant human cardiac L-type Ca 2+ channel 1C subunits by 3-isobutyl-1-methylxanthine

By Fearon I.M.   Palmer A.C.V.   Balmforth A.J.   Ball S.G.   Mikala G.   Peers C.  

European Journal of Pharmacology, Vol. 342, Iss. 2, 1998-01 ,pp. : 353-358

Elsevier

Access to resources Recommend Favorite